Besides the suppression of the anti-tumor activity of T and NK cells by means of arginase 1 and inducible nitric oxide synthase (iNoS) (151–153), MDSCs can foster tumor growth by releasing MMPs that increase the bioavailability of VEGF within the tumor microenvironment (136, 147). Here, VEGFA is linked to neoplasm.